Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care. [Review]
Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care. [Review]
- 2019
PURPOSE OF REVIEW: Review the effectiveness, cost-effectiveness, and implementation challenges of intensive blood pressure (BP) control and team-based care initiatives. RECENT FINDINGS: Intensive BP control is an effective and cost-effective intervention; yet, implementation in routine clinical practice is challenging. Several models of team-based care for hypertension management have been shown to be more effective than usual care to control BP. Additional research is needed to determine the cost-effectiveness of team-based care models relative to one another and as they relate to implementing intensive BP goals. As a focus of healthcare shifts to value (i.e., cost, effectiveness, and patient preferences), formal cost-effectiveness analyses will inform which team-based initiatives hold the highest value in different healthcare settings with different populations and needs. Several challenges, including clinical inertia, financial investment, and billing restrictions for pharmacist-delivered services, will need to be addressed in order to improve public health through intensive BP control and team-based care.
English
1522-6417
10.1007/s11906-019-0996-x [doi] 10.1007/s11906-019-0996-x [pii]
*Antihypertensive Agents/tu [Therapeutic Use]
*Hypertension/dt [Drug Therapy]
Antihypertensive Agents/ec [Economics]
Blood Pressure/de [Drug Effects]
Cardiovascular Diseases/et [Etiology]
Cardiovascular Diseases/mo [Mortality]
Cost-Benefit Analysis
Goals
Humans
Hypertension/co [Complications]
Hypertension/ec [Economics]
Patient Care Team
Randomized Controlled Trials as Topic
Risk Factors
MedStar Heart & Vascular Institute
Journal Article
Review
PURPOSE OF REVIEW: Review the effectiveness, cost-effectiveness, and implementation challenges of intensive blood pressure (BP) control and team-based care initiatives. RECENT FINDINGS: Intensive BP control is an effective and cost-effective intervention; yet, implementation in routine clinical practice is challenging. Several models of team-based care for hypertension management have been shown to be more effective than usual care to control BP. Additional research is needed to determine the cost-effectiveness of team-based care models relative to one another and as they relate to implementing intensive BP goals. As a focus of healthcare shifts to value (i.e., cost, effectiveness, and patient preferences), formal cost-effectiveness analyses will inform which team-based initiatives hold the highest value in different healthcare settings with different populations and needs. Several challenges, including clinical inertia, financial investment, and billing restrictions for pharmacist-delivered services, will need to be addressed in order to improve public health through intensive BP control and team-based care.
English
1522-6417
10.1007/s11906-019-0996-x [doi] 10.1007/s11906-019-0996-x [pii]
*Antihypertensive Agents/tu [Therapeutic Use]
*Hypertension/dt [Drug Therapy]
Antihypertensive Agents/ec [Economics]
Blood Pressure/de [Drug Effects]
Cardiovascular Diseases/et [Etiology]
Cardiovascular Diseases/mo [Mortality]
Cost-Benefit Analysis
Goals
Humans
Hypertension/co [Complications]
Hypertension/ec [Economics]
Patient Care Team
Randomized Controlled Trials as Topic
Risk Factors
MedStar Heart & Vascular Institute
Journal Article
Review